Skip to content

LYNAPHARMA

Active
Private limited companyfounded 20169 yrs activeAlsembergse Steenweg 135, 1060 Sint-Gillis (bij-Brussel), BelgiumKBO/BCE: BE 0666.517.583
Summary

The computed 12-month bankruptcy probability of LYNAPHARMA is 1.6% (moderate). The 2024 annual accounts show equity of €142,374 and a net result of €14,628. Equity is growing by ~7.6% per year across the filed fiscal years. Its solvency ranks better than 83% of 26049 sector peers (fiscal year 2024). The company has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2024
Axes · tick = 2023
Profitability78▼-5
Solvency99▲+2
Growth52=
Track record100
Bankruptcy probability, 12 months
1.6% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €10,000 at 30 days acceptable
Liquidity ample (current ratio 3.49 against 3.37 in 2023; short-term debt: 25.9% and cash: 31% of total assets), and 25.9% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Three signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-09-2025, 60 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 8 filings
Deviation from the deadline
2025
not confirmed
2024
60 d late
2023
61 d late
2022
30 d late
2021
31 d late
2020
61 d late
2019
65 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 51 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

LYNAPHARMA was incorporated on 21 November 2016.1 Total assets rose from EUR 127,566 in 2018 to EUR 192,062 in 2024.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2024

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, micro schema

Equity
€142,374▲ 11.5%
2023 · €127,746
Total assets
€192,062▲ 7.8%
2023 · €178,164
Net result
€14,628▼ 28.1%
2023 · €20,334
Working capital
€123,792▲ 3.8%
2023 · €119,266
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20202021202220232024
Operating result-€4,254€3,068€31,245▲ 919%€26,601▼ 14.9%€19,799▼ 25.6%
Net result-€3,295below the sector's middle half€847within the sector's middle half€25,872above the sector's middle half▲ 2,954%€20,334above the sector's middle half▼ 21.4%€14,628within the sector's middle half▼ 28.1%
Equity€92,693within the sector's middle half▼ 3.4%€93,541within the sector's middle half▲ 0.9%€107,413within the sector's middle half▲ 14.8%€127,746above the sector's middle half▲ 18.9%€142,374above the sector's middle half▲ 11.5%
Total assets€140,374within the sector's middle half▲ 4.6%€146,435within the sector's middle half▲ 4.3%€173,324within the sector's middle half▲ 18.4%€178,164within the sector's middle half▲ 2.8%€192,062within the sector's middle half▲ 7.8%
Debt€47,681▲ 24.6%€52,895▲ 10.9%€65,912▲ 24.6%€50,418▼ 23.5%€49,688▼ 1.4%
Working capital€79,393above the sector's middle half▲ 10.2%€90,241above the sector's middle half▲ 13.7%€101,106above the sector's middle half▲ 12.0%€119,266above the sector's middle half▲ 18.0%€123,792above the sector's middle half▲ 3.8%
Solvency66.0%above the sector's middle half▼ 5.5pp63.9%above the sector's middle half▼ 2.2pp62.0%above the sector's middle half▼ 1.9pp71.7%above the sector's middle half▲ 9.7pp74.1%above the sector's middle half▲ 2.4pp
Current ratio2.67within the sector's middle half▼ 0.222.71within the sector's middle half▲ 0.042.53within the sector's middle half▼ 0.173.37above the sector's middle half▲ 0.833.49above the sector's middle half▲ 0.13
Return on assets (ROA)-2.3%below the sector's middle half▼ 11.7pp0.6%within the sector's middle half▲ 2.9pp14.9%above the sector's middle half▲ 14.3pp11.4%within the sector's middle half▼ 3.5pp7.6%within the sector's middle half▼ 3.8pp
Staff (FTE)0.8within the sector's middle half
above within below the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
-€10,000€0€10,000€20,000€30,000Operating result 2020: -€4,254-€4,254Net result 2020: -€3,295-€3,295Operating result 2021: €3,068€3,068Net result 2021: €847€847Operating result 2022: €31,245€31,245Net result 2022: €25,872€25,872Operating result 2023: €26,601€26,601Net result 2023: €20,334€20,334Operating result 2024: €19,799€19,799Net result 2024: €14,628€14,62820202021202220232024€0€10,000€20,000€30,000Operating result 2022: €31,245€31,200Net result 2022: €25,872€25,900Operating result 2023: €26,601€26,600Net result 2023: €20,334€20,300Operating result 2024: €19,799€19,800Net result 2024: €14,628€14,600202220232024
The operating result has fallen two years in a row; 2024 is 26% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €192,062
Fixed assets €18,582 ▲ 119%
Current assets €173,480 ▲ 2.2%
Equity and liabilities €192,062
Equity €142,374 ▲ 11.5%
Debt €49,688 ▼ 1.4%
Debt's share of the balance-sheet total falls from 28.3% to 25.9%. Equity is higher and debt is lower.
Key figures and ratios
2024 value · change against 2023
EBITDA
€23,225▼
2023 · €28,088
Cash flow
€18,053▼
2023 · €21,821
Quick ratio
2.85▲
2023 · 2.68
Debt to equity
0.35▼
2023 · 0.39
ROE
10.3%▼
2023 · 15.9%
Interest coverage
28.74▼
2023 · 77.01
Debt ≤ 1 year
€49,688▼
2023 · €50,418
Income taxes
€4,979▼
2023 · €5,905
Staff costs
€40,671▲
2023 · €33,795
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 26,975 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 95% are still going.

  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.6% went bankrupt
3.4% stopped otherwise
95% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 1.6% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.9%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 26,975 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 46 lines
Balance sheet Code20232024
Assets
Total assets20/58€178,164€192,062▲
Fixed assets21/28€8,481€18,582▲
Tangible fixed assets22/27€5,181€15,282▲
Plant, machinery and equipment23€1,608€209▼
Furniture and vehicles24€3,573€10,956▲
Other tangible fixed assets26-€4,118
Financial fixed assets28€3,300€3,300=
Current assets29/58€169,683€173,480▲
Amounts receivable after more than one year29€45,000€32,153▼
Other amounts receivable291€45,000€32,153▼
Stocks and contracts in progress3€34,534€31,872▼
Stocks30/36€34,534€31,872▼
Amounts receivable within one year40/41€16,802€49,919▲
Trade receivables40€16,802€38,295▲
Other amounts receivable41-€11,624
Cash at bank and in hand54/58€73,348€59,536▼
Equity and liabilities
Total equity and liabilities10/49€178,164€192,062▲
Equity10/15€127,746€142,374▲
Contributions10/11€60,000€60,000=
Reserves13€6,000€6,000=
Non-distributable reserves130/1€6,000€6,000=
Other1319€6,000€6,000=
Profit (loss) carried forward14€61,746€76,374▲
Amounts payable17/49€50,418€49,688▼
Amounts payable within one year42/48€50,418€49,688▼
Trade debts44€27,140€22,901▼
Suppliers440/4€27,140€22,901▼
Taxes, remuneration and social security45€14,195€21,614▲
Taxes450/3€3,912€12,155▲
Remuneration and social security454/9€10,283€9,460▼
Other amounts payable47/48€9,082€5,173▼
Income statement Code20232024
Remuneration, social security and pensions62€33,795€40,671▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,487€3,426▲
Other operating charges640/8€789€4,636▲
Gross operating margin9900€62,672€68,533▲
Operating profit (loss)9901€26,601€19,799▼
Financial income75/76B€2€615▲
Recurring financial income75€2€615▲
Financial charges65/66B€365€808▲
Recurring financial charges65€365€808▲
Profit (loss) for the period before taxes9903€26,238€19,607▼
Income taxes67/77€5,905€4,979▼
Profit (loss) for the period9904€20,334€14,628▼
Profit (loss) for the period to be appropriated9905€20,334€14,628▼
Appropriation of the result
Profit (loss) to be appropriated9906€61,746€76,374▲
Profit (loss) brought forward from the previous period14P€41,413€61,746▲

The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20202021202220232024Change
Remuneration, social security and pensions62-€40,216€29,438€33,795€40,671▲ 20.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10,675€10,000€1,190€1,487€3,426▲ 130%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€2,183€2,075---
Other operating charges640/8-€1,352€1,433€789€4,636▲ 488%
Gross operating margin9900€40,308€56,819€65,381€62,672€68,533▲ 9.4%
Operating profit (loss)9901-€4,254€3,068€31,245€26,601€19,799▼ 25.6%
Financial income75/76B-€5€5€2€615▲ 31,141%
Recurring financial income75€0€5€5€2€615▲ 31,141%
Financial charges65/66B-€706€139€365€808▲ 122%
Recurring financial charges65€149€706€139€365€808▲ 122%
Profit (loss) for the period before taxes9903-€4,404€2,367€31,111€26,238€19,607▼ 25.3%
Income taxes67/77-€1,109€1,520€5,239€5,905€4,979▼ 15.7%
Profit (loss) for the period9904-€3,295€847€25,872€20,334€14,628▼ 28.1%
Profit (loss) for the period to be appropriated9905-€3,295€847€25,872€20,334€14,628▼ 28.1%
Line20202021202220232024Change
Assets
Total assets20/58€140,374€146,435€173,324€178,164€192,062▲ 7.8%
Fixed assets21/28€13,300€3,300€6,307€8,481€18,582▲ 119%
Intangible fixed assets21€9,000-----
Tangible fixed assets22/27€1,000-€3,007€5,181€15,282▲ 195%
Plant, machinery and equipment23--€3,007€1,608€209▼ 87.0%
Furniture and vehicles24---€3,573€10,956▲ 207%
Other tangible fixed assets26----€4,118-
Financial fixed assets28€3,300€3,300€3,300€3,300€3,300=
Current assets29/58€127,074€143,135€167,018€169,683€173,480▲ 2.2%
Amounts receivable after more than one year29--€45,000€45,000€32,153▼ 28.5%
Other amounts receivable291--€45,000€45,000€32,153▼ 28.5%
Stocks and contracts in progress3€46,469€44,123€46,661€34,534€31,872▼ 7.7%
Stocks30/36-€44,123€46,661€34,534€31,872▼ 7.7%
Amounts receivable within one year40/41€23,557€28,145€18,540€16,802€49,919▲ 197%
Trade receivables40-€23,165€18,540€16,802€38,295▲ 128%
Other amounts receivable41-€4,980--€11,624-
Cash at bank and in hand54/58€55,886€70,867€56,817€73,348€59,536▼ 18.8%
Equity and liabilities
Total equity and liabilities10/49€140,374€146,435€173,324€178,164€192,062▲ 7.8%
Equity10/15€92,693€93,541€107,413€127,746€142,374▲ 11.5%
Contributions10/11€60,000€60,000€60,000€60,000€60,000=
Capital10-€60,000----
Issued capital100-€60,000----
Reserves13€6,000€6,000€6,000€6,000€6,000=
Non-distributable reserves130/1-€6,000€6,000€6,000€6,000=
Legal reserve130-€6,000----
Other1319--€6,000€6,000€6,000=
Profit (loss) carried forward14€26,693€27,541€41,413€61,746€76,374▲ 23.7%
Amounts payable17/49€47,681€52,895€65,912€50,418€49,688▼ 1.4%
Amounts payable within one year42/48€47,681€52,895€65,912€50,418€49,688▼ 1.4%
Trade debts44€23,607€35,364€35,441€27,140€22,901▼ 15.6%
Suppliers440/4-€35,364€35,441€27,140€22,901▼ 15.6%
Taxes, remuneration and social security45-€12,506€13,632€14,195€21,614▲ 52.3%
Taxes450/3-€5,298€3,566€3,912€12,155▲ 211%
Remuneration and social security454/9-€7,208€10,066€10,283€9,460▼ 8.0%
Other amounts payable47/48-€5,025€16,840€9,082€5,173▼ 43.0%
Line20202021202220232024Change
Profit (loss) for the period9904-€3,295€847€25,872€20,334€14,628▼ 28.1%
+ Depreciation and write-downs630€10,675€10,000€1,190€1,487€3,426▲ 130%
Operating cash flow (approximation)€7,380€10,847€27,063€21,821€18,053▼ 17.3%
Investment in fixed assets (approximation)-€0-€4,197-€3,662-€13,527▼ 269%
Change in cash-€14,982-€14,050€16,530-€13,812▼ 184%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2025
29-09
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 60 days late
2024
30-09
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 61 days late
2023
30-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 30 days late
2022
31-12
Financial Highest result since 2018net €25,872 ▲2,954%
Operating result €31,245, net result €25,872, both a record.
31-12
Financial Equity above €100,000Eq €107,413 ▲14.8%
2 profitable years in a row build equity to €107,413.
31-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-12
Financial Back to profitnet €847
Net result €847 after one loss-making year.
30-09
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 61 days late
2020
31-12
Financial Weakest financial yearnet -€3,295
Net result drops to -€3,295, the lowest in the series; recovery starts the following year.
04-10
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 65 days late
2019
30-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 30 days late
2018
31-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Gillis (bij-Brussel) · 1 establishment unit since 2017
seat establishment The establishment unit on the map
Ground area
94 m²
Building footprint
89 m²
Volume, LiDAR
1,366 m³
Parcel 21562A0195/00L002, Brussels · tallest building 20.5 m, ±5 floors. Linked by address, not a title deed.
4 companies at this address See who is registered here
1 establishment unit
LYNAPHARMA
Alsembergse Steenweg 135, 1060 Sint-Gillis (bij-Brussel)Retail sale of pharmaceutical products
since 20172.260.253.022
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21562A0195/00L002 Brussels 94 m² 1 · 88 m² 20.5 m · 5 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 3,560 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded21-11-2016
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
47750Retail sale of cosmetics and toilet articles
E-invoicing
Reachable via Peppol
Peppol ID 0208:0666517583
Registered 27-03-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.